Molina Healthcare (NYSE:MOH) Posts Quarterly Earnings Results, Beats Expectations By $0.55 EPS

Molina Healthcare (NYSE:MOH) announced its quarterly earnings results on Tuesday. The company reported $3.11 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.56 by $0.55, Fidelity Earnings reports. Molina Healthcare had a net margin of 4.35% and a return on equity of 49.21%. The business had revenue of $4.19 billion for the quarter, compared to analysts’ expectations of $4.08 billion. During the same quarter last year, the firm earned $3.08 EPS. The firm’s revenue for the quarter was down 14.1% compared to the same quarter last year. Molina Healthcare updated its FY 2019 guidance to $11.20-11.50 EPS and its FY19 guidance to $11.20-11.50 EPS.

Molina Healthcare stock traded down $0.96 during mid-day trading on Friday, reaching $129.29. The company’s stock had a trading volume of 389,145 shares, compared to its average volume of 415,279. Molina Healthcare has a 12-month low of $105.28 and a 12-month high of $159.00. The firm has a market cap of $8.16 billion, a P/E ratio of 11.67, a P/E/G ratio of 0.95 and a beta of 1.28. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.74. The stock has a fifty day moving average of $142.31.

Several research firms have commented on MOH. BMO Capital Markets raised shares of Molina Healthcare from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $154.00 to $200.00 in a research report on Monday, June 3rd. ValuEngine cut shares of Molina Healthcare from a “hold” rating to a “sell” rating in a report on Thursday. Bank of America reaffirmed an “underperform” rating and issued a $140.00 price target (up previously from $132.00) on shares of Molina Healthcare in a report on Wednesday. Wells Fargo & Co raised shares of Molina Healthcare from a “market perform” rating to an “outperform” rating and set a $177.00 price target on the stock in a report on Friday, May 31st. Finally, Barclays lifted their price target on shares of Molina Healthcare from $140.00 to $149.00 and gave the stock an “equal weight” rating in a report on Friday, May 31st. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. Molina Healthcare currently has an average rating of “Buy” and an average target price of $160.92.

In related news, Director Garrey Carruthers sold 1,300 shares of the company’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $152.75, for a total value of $198,575.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Daniel Cooperman sold 4,004 shares of the business’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $155.00, for a total transaction of $620,620.00. Following the completion of the sale, the director now directly owns 4,096 shares of the company’s stock, valued at $634,880. The disclosure for this sale can be found here. Insiders have sold a total of 6,304 shares of company stock valued at $945,495 over the last 90 days. Company insiders own 0.77% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Featured Story: Penny Stocks

Earnings History for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with's FREE daily email newsletter.